NCT05932030 (TransplantIA) is a NA clinical trial of Survey in Solid Organ Transplantation, sponsored by University Hospital, Grenoble.

Who is sponsoring NCT05932030?

NCT05932030 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT05932030?

Interventions in NCT05932030: Survey.

What condition does NCT05932030 study?

NCT05932030 studies Solid Organ Transplantation, Artificial Intelligence.

Is NCT05932030 still recruiting?

NCT05932030 is currently status unknown. Last updated 6 July 2023.

Last reviewed 2023-07-06 · How we verify

NCT05932030: TransplantIA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Knowledge and Perceptions of Artificial Intelligence in Solid Organ Transplantation

Status unknown NA Last updated 6 July 2023

What this trial tests

NA trial testing Survey in Solid Organ Transplantation in 6,750 participants. Status unknown.

Timeline

1 July 2023

Primary endpoint
1 December 2023

1 December 2023

Quick facts

Lead sponsor	University Hospital, Grenoble
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	6,750
Start date	1 July 2023
Primary completion	1 December 2023
Estimated completion	1 December 2023

Drugs / interventions tested

Survey

Conditions studied

Solid Organ Transplantation — all drugs for Solid Organ Transplantation →
Artificial Intelligence — all drugs for Artificial Intelligence →

Sponsor

University Hospital, Grenoble

Who can join

18 and older, any sex, with Solid Organ Transplantation or Artificial Intelligence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The increasing abundance of clinical, genetic, radiological, and metabolic data in transplantation has led to a growing interest in applying artificial intelligence (AI) tools to optimize immunosuppression and overall patient management. However, the majority of these applications exist only in the preclinical state and the field of artificial intelligence remains unknown to the general public. In view of the potential applications of AI and the growing research interest in this topic, it is essential to assess the knowledge and perceptions of those directly involved in solid organ transplantation. Primary Objective: To assess the knowledge and perceptions of solid organ transplant patients and healthcare professionals working in the field of solid organ transplantation Primary endpoint: * Analysis of verbatim and closed-ended questionnaire data * Comparison of the averages obtained by the subgroups of patients and health professionals and analysis of the verbatim by grouping them by themes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Survey

Trials testing the same drug.

NCT07452159 — Diabetes In Asians at Risk in Youth · not yet recruiting
NCT07294703 — Factors Associated With Breast Cancer Risks and Outcomes · recruiting
NCT07330739 — Kinesiophobia in Women With Stress Urinary Incontinence · active not recruiting
NCT07215039 — Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida · enrolling by invitation
NCT07220096 — Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Pati · recruiting

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05932030 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 6 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05932030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing